NEW YORK, Oct. 16 - Millennium Pharmaceuticals on Tuesday reported narrowed third-quarter losses as revenue from strategic alliances nearly doubled. 

The Cambridge, Mass.-based company said its loss from operations narrowed to $9.5 million, or 4 cents a share, from a loss of $31.9 million, or 16 cents, year over year. 

Revenues from alliances grew to $82 million over the current quarter from $44 million over the same period last year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.